Astaxanthin - Mera

Drug Profile

Astaxanthin - Mera

Alternative Names: AstaFactor

Latest Information Update: 20 Sep 2002

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Mera Pharmaceuticals
  • Class Anti-inflammatories; Antineoplastics; Xanthophylls
  • Mechanism of Action Antioxidants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cardiovascular disorders; Exercise-induced asthma; Macular degeneration

Most Recent Events

  • 20 Sep 2002 Aquasearch is now called Mera Pharmaceuticals
  • 11 Jun 2002 No development reported - Clinical-Phase-Unknown for Cardiovascular disorders in USA (PO)
  • 11 Jun 2002 No development reported - Clinical-Phase-Unknown for Exercise-induced asthma in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top